Ignite Creation Date:
2024-07-17 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06495814
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-11
First Post:
2024-07-02
Brief Title:
Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus
Sponsor:
Fengmei Lian
Organization:
Guanganmen Hospital of China Academy of Chinese Medical Sciences
Study Overview
Official Title:
Characterization and Mechanism Research of the Pre-disease State of Obese Type 2 Diabetes Mellitus
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Establish a comprehensive evaluation system for the progression of obese impaired glucose tolerance IGT to type 2 diabetes mellitus T2DM through cross-sectional studies Constructing and validating a T2DM risk prediction model for obese IGT population through observational research Through open-label clinical research we applied Jinlida granules to intervene in high-risk obese IGT population and clarify its protective effect on this population
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None